表紙
市場調查報告書

神經修複用生物材料 (生醫材料)的全球市場:趨勢·預測

Global Nerve Repair Biomaterials Market - Trends and Forecast to 2024

出版商 Data Bridge Market Research Private Limited 商品編碼 536504
出版日期 內容資訊 英文 229 Pages; 218 Tables; 32 Figures
商品交期: 最快1-2個工作天內
價格
神經修複用生物材料 (生醫材料)的全球市場:趨勢·預測 Global Nerve Repair Biomaterials Market - Trends and Forecast to 2024
出版日期: 2017年05月31日內容資訊: 英文 229 Pages; 218 Tables; 32 Figures
簡介

本報告提供全球神經修複用生物材料 (生醫材料)的市場調查,提供市場定義和概要,市場的各種影響因素及市場機會分析,產品類型·創傷類型·終端用戶·地區/各主要國家趨勢與市場規模的變化與預測,競爭環境,並彙整主要企業的簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 市場環境:摘要

第4章 重要考察

  • 概要
  • 重要考察
  • 市場概要
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會
    • 威脅
  • 市場趨勢·新興技術

第5章 摘要整理

第6章 市場分析:各產品類型

  • 概要
  • 神經修復
    • 神經管
    • 神經移植片
  • 神經保護
    • 神經保護器
    • NERVE WRAP

第7章 市場分析:創傷類別

  • 概要
  • 神經鞘修復
  • 神經周圍修復
  • 神經纖維束群縫合法

第8章 市場分析:各終端用戶

  • 概要
  • 醫院
  • 門診病人外傷中心
  • 診療所

第9章 地區分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 土耳其
    • 比利時
    • 荷蘭
    • 瑞士
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 韓國
    • 印度
    • 澳洲
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 巴西
    • 其他
  • 中東·非洲
    • 南非
    • 其他

第10章 競爭環境

  • 企業佔有率分析:各地區
  • M&A
  • 新產品的開發·核准
  • 擴張
  • 法律規章上的變更
  • 聯盟·其他

第11章 企業簡介

第12章 附錄

目錄

Synopsis:

Global Nerve Repair Biomaterials Market is expected to reach USD 775.6 million by 2024, at a CAGR of 11.3% during the forecast period of 2017 to 2024. The report contains 203 pages of exclusive premium insights with 218 tables and 32 figures.

The global nerve repair biomaterials market is witnessing a rapid growth due to increasing geriatric population, increasing incidence of nerve injuries and neurological disorders, favourable reimbursement policies, and increased government funding. The demand for nerve repair biomaterials is increasing in the hospitals followed by ambulatory trauma centres due to increasing aging population and rising number of nerve injuries and nerve surgeries.

The Global Nerve Repair Biomaterials Market has been segmented On the basis of product type into nerve repair and nerve protection. The nerve repair biomaterials market is further segmented into nerve conduits and, nerve grafts. Nerve Repair Graft is further segmented into allograft and acellularized allograft. Nerve protection market is segmented into nerve protector and nerve wrap.

On the basis of end user, the nerve repair biomaterial market is categorized into hospitals, clinics, and ambulatory surgical centres.

Based on the injury type, the nerve repair biomaterial market is segmented into epineural nerve repair, perineural nerve repair, and group fascicular repair.

The global nerve repair biomaterials market is segmented into geographical regions, North & South America, Europe, Asia-Pacific and, Middle East & Africa. These regions are further classified on the basis of country, into major countries such as U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others. The report includes market shares of nerve repair biomaterial market for global, Europe, North America, Asia Pacific and Rest of the World.

Major Players Operating in this market:

Axogen, Inc., Polyganics, B.V., Checkpoint Surgical, Inc. and, Synovis Micro Companies Alliance, Inc. among others.

Regions Covered In The Scope Of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))

Table of Contents

1. INTRODUCTION

  • 1.1. OVERVIEW OF THE NERVE REPAIR BIOMATERIALS MARKET
  • 1.2. MARKET SEGMENTATION & COVERAGE
    • 1.2.1. CURRENCY AND PRICING
    • 1.2.2. LIMITATION
    • 1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET SIZE
    • 2.2.1. MARKET CRACKDOWN APPROACH
    • 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
    • 2.2.3. DATA TRIANGULATION
    • 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
    • 2.2.6. PORTER'S FIVE FORCES MATRIX
  • 2.4. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: RESEARCH SNAPSHOT
  • 2.5. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. OVERVIEW
  • 4.2. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: KEY PRIMARY INSIGHTS
  • 4.3. MARKET OVERVIEW
    • 4.3.1. DRIVERS
      • 4.3.1.1. INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES
      • 4.3.1.2. TECHNOLOGICAL DEVELOPMENT IN NERVE REPAIR
      • 4.3.1.3. FAVORABLE REIMBURSEMENT POLICIES
      • 4.3.1.4. EXPANDED TARGET APPLICATIONS
    • 4.3.2. RESTRAINTS
      • 4.3.2.1. LACK OF PATIENT AWARENESS
      • 4.3.2.2. LACK OF PROFESSIONALS, INCLUDING TRAINED SURGEONS
    • 4.3.3. OPPURTUNITIES
      • 4.3.3.1. NOVEL THERAPIES SUCH AS STEM CELL THERAPY
      • 4.3.3.2. RISING ACCEPTANCE OF EMERGING MARKETS
    • 4.3.4. THREATS
      • 4.3.4.1. DONOR SITE MORBIDITY
      • 4.3.4.2. INADEQUATE NERVE REGENERATION BY CONDUITS
  • 4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. EXECUTIVE SUMMARY

6. NERVE REPAIR BIOMATERIALS MARKET, BY PRODUCT TYPE

  • 6.1. OVERVIEW
  • 6.2. NERVE REPAIR
    • 6.2.1. NERVE CONDUITS
    • 6.2.2. NERVE GRAFTS
      • 6.2.2.1. ALLOGRAFTS
      • 6.2.2.2. ACELLULARIZED ALLOGRAFTS
  • 6.3. NERVE PROTECTION
    • 6.3.1. NERVE PROTECTOR
    • 6.3.2. NERVE WRAP

7. NERVE REPAIR BIOMATERIALS MARKET, BY INJURY TYPE

  • 7.1. OVERVIEW
  • 7.2. EPINEURAL NERVE REPAIR
  • 7.3. PERINEURAL NERVE REPAIR
  • 7.4. GROUP FASCICULAR NERVE REPAIR

8. NERVE REPAIR BIOMATERIALS MARKET, BY END USER

  • 8.1. OVERVIEW
  • 8.2. HOSPITALS
  • 8.3. AMBULATORY TRAUMA CENTERS
  • 8.4. CLINICS

9. NERVE REPAIR BIOMATERIALS MARKET, BY GEOGRAPHY

  • 9.1. COUNTRYWISE NERVE REPAIR BIOMATERIALS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
    • 9.1.1. NORTH AMERICA
      • 9.1.1.1. U.S.
      • 9.1.1.2. CANADA
      • 9.1.1.3. MEXICO
    • 9.1.2. EUROPE
      • 9.1.2.1. GERMANY
      • 9.1.2.2. FRANCE
      • 9.1.2.3. U.K.
      • 9.1.2.4. ITALY
      • 9.1.2.5. SPAIN
      • 9.1.2.6. RUSSIA
      • 9.1.2.7. TURKEY
      • 9.1.2.8. BELGIUM
      • 9.1.2.9. NETHERLANDS
      • 9.1.2.10. SWITZERLAND
      • 9.1.2.11. REST OF EUROPE
    • 9.1.3. ASIA-PACIFIC (APAC)
      • 9.1.3.1. JAPAN
      • 9.1.3.2. CHINA
      • 9.1.3.3. SOUTH KOREA
      • 9.1.3.4. INDIA
      • 9.1.3.5. AUSTRALIA
      • 9.1.3.6. SINGAPORE
      • 9.1.3.7. THAILAND
      • 9.1.3.8. MALAYSIA
      • 9.1.3.9. INDONESIA
      • 9.1.3.10. PHILIPPINES
      • 9.1.3.11. REST OF APAC
    • 9.1.4. LATIN AMERICA
      • 9.1.4.1. BRAZIL
      • 9.1.4.2. REST OF LATIN AMERICA
    • 9.1.5. MIDDLE EAST AND AFRICA
      • 9.1.5.1. SOUTH AFRICA
      • 9.1.5.2. REST OF MIDDLE EAST AND AFRICA
  • 9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. NERVE REPAIR BIOMATERIALS MARKET: COMPETITIVE LANDSCAPE

  • 10.1. GLOBAL NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.2. U.S. NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.3. EUROPE NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.4. APAC NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.5. SOUTH AMERICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.6. MIDDLE EAST AND AFRICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.7. MERGERS & ACQUISITIONS
  • 10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 10.10. EXPANSIONS
  • 10.10. REGULATORY CHANGES
  • 10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11. NERVE REPAIR BIOMATERIALS MARKET, COMPANY PROFILES

  • 11.1. AXOGEN, INC.
    • 11.1.1. COMPANY OVERVIEW
    • 11.1.2. SWOT ANALYSIS
    • 11.1.3. REVENUE ANALYSIS
    • 11.1.4. PRODUCT PORTFOLIO
    • 11.1.5. RECENT DEVELOPEMENTS
    • 11.1.5. DATA BRIDGE ANALYSIS
  • 11.2. CHECKPOINT SURGICAL, INC.
    • 11.2.1. COMPANY OVERVIEW
    • 11.2.2. SWOT ANALYSIS
    • 11.2.3. REVENUE ANALYSIS
    • 11.2.4. PRODUCT PORTFOLIO
    • 11.2.5. RECENT DEVELOPEMENTS
    • 11.2.5. DATA BRIDGE ANALYSIS
  • 11.3. COLLAGEN MATRIX, INC.
    • 11.3.1. COMPANY OVERVIEW
    • 11.3.2. SWOT ANALYSIS
    • 11.3.3. REVENUE ANALYSIS
    • 11.3.4. PRODUCT PORTFOLIO
    • 11.3.5. RECENT DEVELOPEMENTS
    • 11.3.5. DATA BRIDGE ANALYSIS
  • 11.4. INTEGRA LIFESCIENCES CORPORATION
    • 11.4.1. COMPANY OVERVIEW
    • 11.4.2. SWOT ANALYSIS
    • 11.4.3. REVENUE ANALYSIS
    • 11.4.4. PRODUCT PORTFOLIO
    • 11.4.5. RECENT DEVELOPEMENTS
    • 11.4.5. DATA BRIDGE ANALYSIS
  • 11.5. POLYGANICS B.V.
    • 11.5.1. COMPANY OVERVIEW
    • 11.5.2. SWOT ANALYSIS
    • 11.5.3. REVENUE ANALYSIS
    • 11.5.4. PRODUCT PORTFOLIO
    • 11.5.5. RECENT DEVELOPEMENTS
    • 11.5.5. DATA BRIDGE ANALYSIS
  • 11.6. STRYKER CORPORATION
    • 11.6.1. COMPANY OVERVIEW
    • 11.6.2. SWOT ANALYSIS
    • 11.6.3. REVENUE ANALYSIS
    • 11.6.4. PRODUCT PORTFOLIO
    • 11.6.5. RECENT DEVELOPEMENTS
    • 11.6.5. DATA BRIDGE ANALYSIS
  • 11.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC.
    • 11.7.1. COMPANY OVERVIEW
    • 11.7.2. SWOT ANALYSIS
    • 11.7.3. REVENUE ANALYSIS
    • 11.7.4. PRODUCT PORTFOLIO
    • 11.7.5. RECENT DEVELOPEMENTS
    • 11.7.5. DATA BRIDGE ANALYSIS

12. APPENDIX

13. ABOUT DATA BRIDGE MARKET RESEARCH